NGEN
NervGen Pharma Corp.
1.80$
+1.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | +125.1% | -3.7% | +169.5% | +31.2% | -44.1% | +47.1% | +19.2% | |
| – | – | +152.9% | -3.3% | +182.4% | +30.7% | -45.4% | +51.8% | +20.0% | |
| – | – | +71.0% | +33.0% | +204.0% | +30.5% | -47.6% | +48.0% | +27.9% | |
| – | – | +71.0% | +33.0% | +204.0% | +30.5% | -47.6% | +48.8% | +27.2% | |
| – | – | +388.5% | -50.1% | +2.8% | -58.5% | +834.1% | +65.9% | -80.5% | |
| – | – | -4.1% | -9.8% | +0.9% | -10.3% | +21.8% | -10.8% | -11.9% | |
| – | – | +63.3% | -20.3% | +43.5% | +850.3% | +47.7% | +10.8% | +16.8% | |
| – | – | +112.1% | -20.3% | +43.5% | +832.3% | +49.5% | +11.6% | +16.8% | |
| – | – | – | – | – | – | +7.1% | +6.1% | -91.4% | |
| – | – | – | – | – | – | +65.9% | – | – | |
| – | – | +139.4% | -1.1% | +185.6% | -21.3% | -115.1% | – | +35.0% | |
| – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -4.8% | +24.0% | +22.4% | +34.0% | +12.6% | +13.5% | +7.4% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.